Christophe Tournigand
- Oncology top 0.2%
- Colorectal Cancer Treatments and Studies 122
- Cancer Treatment and Pharmacology 61
- Colorectal Cancer Surgical Treatments 23
- Pancreatic and Hepatic Oncology Research 18
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Geriatrics and Gerontology top 0.5%
- Frailty in Older Adults 21
- Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes 41
-
- Genetic factors in colorectal cancer 26
- Co-authors
- Aimery de GramontThierry AndréChristophe LouvetGérard LledoMarc BuysePhilippe ColinEmmanuel QuinauxEmmanuel Achille
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Christophe Tournigand
246 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 7.0k
- Hepatology 2.0k
- Geriatrics and Gerontology 505
- Pulmonary and Respiratory Medicine 3.0k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Christophe Tournigand
This map shows the geographic impact of Christophe Tournigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Tournigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Tournigand more than expected).
Fields of papers citing papers by Christophe Tournigand
This network shows the impact of papers produced by Christophe Tournigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Tournigand. The network helps show where Christophe Tournigand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christophe Tournigand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 4 | |
| 7 | Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Studybreakdown → | 2022 | 220 |
| 8 | 2022 | 72 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 24 | |
| 11 | 2019 | 70 | |
| 12 | 2018 | 14 | |
| 13 | 2018 | 41 | |
| 14 | 2017 | 75 | |
| 15 | PROGNOSTIC VALUE OF EARLY OBJECTIVE TUMOR RESPONSE (EOTR) TO FIRST LINE SYSTEMIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS OF RANDOMIZED TRIALS FROM THE ARCAD DATABASE | 2013 | 2 |
| 16 | 2011 | 72 | |
| 17 | 2009 | 262 | |
| 18 | [Use of complementary medicine by cancer patients in a French oncology department]. | 2007 | 44 |
| 19 | Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC* | 2006 | 1 |
| 20 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Studybreakdown → | 2003 | 2290 |
About Christophe Tournigand
Christophe Tournigand is a scholar working on Oncology, Geriatrics and Gerontology and Hepatology, having authored 256 papers that have together received 9.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (122 papers), Cancer Treatment and Pharmacology (61 papers), Gastric Cancer Management and Outcomes (41 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers), Genetic factors in colorectal cancer (26 papers), Colorectal Cancer Surgical Treatments (23 papers), Frailty in Older Adults (21 papers) and Pancreatic and Hepatic Oncology Research (18 papers). The work is most often cited by research in Oncology (7.0k citations), Hepatology (2.0k citations) and Geriatrics and Gerontology (505 citations). Christophe Tournigand has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Aimery de Gramont, Thierry André, Christophe Louvet, Gérard Lledo, Marc Buyse, Philippe Colin, Emmanuel Quinaux, Emmanuel Achille, G. Ganem and C. Couteau. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.